Effect of exogenous bFGF on the proliferation of human adenoid cystic carcinoma ACC-2 cells

Abstract

To observe the effects of basic fibroblast growth factor (bFGF) on human adenoid cystic carcinoma ACC-2 cell line proliferation and ERK, cyclin D1/p21^waf/cip1 signaling pathways, human adenoid cystic carcinoma cells (ACC-2) were cultured and the influence of bFGF of different concentrations on cell proliferation was determined by MTT. Protein was detected by immuno-precipitation and ERK activity by using ERK agent kit. p-ERK_1/2 and down-stream cyclin D1, p21^waf/cip1 expression were detected by Western blotting and the interfering role of mitogen protein-activated kinase (MEK) suppressor U0126 in the afore-mentioned indicators was examined. MTT demonstrated ACC-2 cell proliferation was substantially enhanced by bFGF, immuno-precipitation displayed ERK activity was up-regulated by bFGF, and immuno-imprinting also showed p-ERK_1/2, cyclin D1 expression was greatly enhanced and p21^waf/cip1 expression was inhibited by bFGF. U0126 suppressed the effect of bFGF. It is concluded that bFGF can promote the proliferation of human adenoid cystic carcinoma ACC-2 cells, and its pathways are associated with the up-regulated activity and expression of p-ERK_1/2, inhibited p21waf/cip1 expression and enhanced cyclin D1 expression.

Keywords

basic fibroblast growth factor / adenoid cystic carcinoma / extracellular signal-regulated kinase / cell cycle phase protein D1

References

[1] NongX. L., WangD. Z., MengM., et al.. Combining of TNP-470 and 5-Fuin inhibition of adenoid cystic carcinomain nude mice model. West Chin J Stomatol (Chinese), 2004, 22(4): 267-269

[2] YamamotoY., VirmaniA. K., WistubaI. I., et al.. Loss of beterozygosity and microsatellite alterations in p53 and RB genes in adenoid cystic carcinoma of the salivary glands. Hum Pathol, 1996, 27(11): 1204-1206

[3] AndresenB. T., RizzoM. A., ShomeK., et al.. The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade. FEBS Lett, 2002, 531(1): 65-68

[4] WebbC. P., van AelstL., WiglerM. H., et al.. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci, 1998, 95(15): 8773

[5] Weinstein-OppenheimerC. R., BlalockW. L., SteelmanL. S., et al.. The raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumour. Pharmacol Ther, 2000, 88(3): 229-231

[6] EguchiS., InagamiT.. Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regulatory Peptides, 2000, 91: 13-20

[7] SolitD. B., GarrawayL. A., PratilasC. A., et al.. BRAF mutation predicts sensitivity to MEK inhibition. Nature, 2005, 439(7074): 358-360

[8] FavataM. F., HoriuchiK. Y., ManosE. J., et al.. Identification of a novel mitogeninhibitor of mitogen-activated protein kinase kinase. J Biol Chem, 1998, 273(29): 18623-18625

[9] JohnsonG. L., LapadatR.. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 2002, 298(5600): 1911-1912

[10] GolsteinP.. Control cell death. Science, 1997, 275(5303): 1081-1082

[11] HaradaK., KurisuK., SadatomoT., et al.. Growth inhibition of human glioma cells by transfection-induced p21 and its effects on telomerase activity. J Neurooncol, 2000, 47(1): 39-46

[12] AndresenB. T., RizzoM. A., ShomeK., et al.. The role of phosphatidic acidin the regulation of the Ras/MEK/Erk signaling cascade. FEBS Lett., 2002, 531(1): 65-68